Not a good buy right now for an impatient entry: price (8.08 pre-market) is sitting just above the pivot (7.97) and below near-term resistance (8.34), while the pattern-based forward odds lean slightly negative over the next day/week.
Trend is constructive (bullish moving-average stack + positive MACD), but there is no Intellectia buy signal to justify chasing immediately.
Upside to Street targets exists (~$8.50–$9.00), but it’s relatively modest versus the likely short-term chop.
RSI(6): 60.83 (neutral-to-bullish), not yet overbought.
Key levels: Pivot 7.97 (near-term line-in-the-sand). Resistance R1 8.341 then R2 8.569; Support S1 7.599 then S2 7.371.
Short-horizon statistical outlook (similar candlestick patterns): 80% chance of -0.91% next day, -2.67% next week, -2.02% next month—suggests limited near-term edge to buy immediately at 8.08.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Put/Call OI ratio 0.42 (call-heavy), generally a bullish/less-defensive positioning signal.
Activity: Options volume is effectively zero today (no meaningful confirmation from flow).
Volatility: 30D IV 66.41 vs historical vol 28.9 (elevated implied vol); IV percentile 58.57 suggests options are priced relatively rich vs its own range.
Net takeaway: Sentiment from OI is supportive, but the lack of volume/flow reduces signal strength.
Technical Summary
Sell
1
Buy
9
Positive Catalysts
Analyst optimism tied to fundamentals: expectation that net interest margin can rise as liabilities reprice downward while asset yields stay sticky.
Latest quarter growth is strong (revenue, net income, EPS all up double-digits YoY), supportive for re-rating.
Balance sheet described by analysts as “ultra conservative,” and dividend viewed as attractive/sustainable (supportive for downside).
Neutral/Negative Catalysts
with statistical near-term drift slightly negative; could mean a pullback before a better entry.
Recent trend: price targets have been raised and bullish ratings maintained.
2026-01-27 (Keefe Bruyette): PT raised to $8.50 from $7, kept Outperform; expects NIM to increase moderately.
2025-12-10 (Piper Sandler): PT raised to $9.00 from $7.50, kept Overweight; sees NIM rising through 2026, conservative balance sheet, sustainable dividend.
Wall St pros: improving NIM outlook, conservative balance sheet, dividend support.
Wall St cons: upside to targets from 8.08 is present but not huge; near-term price may stall under resistance without a catalyst.
Wall Street analysts forecast KRNY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KRNY is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast KRNY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KRNY is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Buy
Hold
Sell
0
Current: 8.060
Low
0
Averages
0
High
0
0
Current: 8.060
Low
0
Averages
0
High
0
Keefe Bruyette
David Konrad
Outperform
maintain
$7
AI Analysis
2026-01-27
Reason
Keefe Bruyette
David Konrad
Price Target
$7
AI Analysis
2026-01-27
maintain
Outperform
Reason
Keefe Bruyette analyst David Konrad raised the firm's price target on Kearny Financial to $8.50 from $7 and keeps an Outperform rating on the shares. Net interest margin is likely to increase moderately from here, the analyst tells investors in a research note.
Piper Sandler
Overweight
maintain
$9
2025-12-10
Reason
Piper Sandler
Price Target
$9
2025-12-10
maintain
Overweight
Reason
Piper Sandler raised the firm's price target on Kearny Financial to $9 from $7.50 and keeps an Overweight rating on the shares. The firm would consider Kearny to be one of the more liability-sensitive banks in its coverage space and expects the net interest margin to steadily rise across 2026 as liabilities reprice downward and asset yields remain a bit sticky. Piper views the balance sheet as ultra conservative. Lastly, the firm sees the dividend as attractive and sustainable.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for KRNY
